CY1112438T1 - Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη - Google Patents

Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη

Info

Publication number
CY1112438T1
CY1112438T1 CY20111100452T CY111100452T CY1112438T1 CY 1112438 T1 CY1112438 T1 CY 1112438T1 CY 20111100452 T CY20111100452 T CY 20111100452T CY 111100452 T CY111100452 T CY 111100452T CY 1112438 T1 CY1112438 T1 CY 1112438T1
Authority
CY
Cyprus
Prior art keywords
acute renal
soluble
thrombodouline
treatment
renal deficiency
Prior art date
Application number
CY20111100452T
Other languages
Greek (el)
English (en)
Inventor
Brian William Grinnell
Thurman Dwight Mckinney
Bruce A Molitoris
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1112438T1 publication Critical patent/CY1112438T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CY20111100452T 2005-10-13 2011-05-13 Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη CY1112438T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72637605P 2005-10-13 2005-10-13
EP06825898A EP1948216B1 (en) 2005-10-13 2006-10-12 Treatment of acute renal failure with soluble thrombomodulin

Publications (1)

Publication Number Publication Date
CY1112438T1 true CY1112438T1 (el) 2015-12-09

Family

ID=37670944

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100452T CY1112438T1 (el) 2005-10-13 2011-05-13 Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη

Country Status (13)

Country Link
US (1) US20080255047A1 (cg-RX-API-DMAC7.html)
EP (1) EP1948216B1 (cg-RX-API-DMAC7.html)
JP (1) JP5405829B2 (cg-RX-API-DMAC7.html)
AT (1) ATE503489T1 (cg-RX-API-DMAC7.html)
CA (1) CA2625888C (cg-RX-API-DMAC7.html)
CY (1) CY1112438T1 (cg-RX-API-DMAC7.html)
DE (1) DE602006021048D1 (cg-RX-API-DMAC7.html)
DK (1) DK1948216T3 (cg-RX-API-DMAC7.html)
ES (1) ES2360610T3 (cg-RX-API-DMAC7.html)
PL (1) PL1948216T3 (cg-RX-API-DMAC7.html)
PT (1) PT1948216E (cg-RX-API-DMAC7.html)
SI (1) SI1948216T1 (cg-RX-API-DMAC7.html)
WO (1) WO2007047430A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073884A2 (en) * 2006-12-12 2008-06-19 Eli Lilly And Company Treating acute renal failure with soluble thrombomodulin variants
WO2010056472A2 (en) * 2008-11-12 2010-05-20 Eli Lilly And Company Compositions and methods of use for thrombomodulin variants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
DE69333491T2 (de) * 1992-02-05 2005-03-31 Paion Gmbh Protease-Resistant Thrombomodulin Analogs
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
CA2515916A1 (en) * 2003-02-25 2004-09-10 Biovec B.V. Therapeutic applications of thrombomodulin gene via viral and non-viral vectors

Also Published As

Publication number Publication date
CA2625888A1 (en) 2007-04-26
CA2625888C (en) 2015-09-22
PL1948216T3 (pl) 2011-10-31
ES2360610T3 (es) 2011-06-07
WO2007047430A8 (en) 2008-04-10
EP1948216B1 (en) 2011-03-30
WO2007047430A3 (en) 2007-05-24
PT1948216E (pt) 2011-05-06
JP2009511597A (ja) 2009-03-19
JP5405829B2 (ja) 2014-02-05
EP1948216A2 (en) 2008-07-30
SI1948216T1 (sl) 2011-07-29
US20080255047A1 (en) 2008-10-16
DE602006021048D1 (de) 2011-05-12
WO2007047430A2 (en) 2007-04-26
ATE503489T1 (de) 2011-04-15
DK1948216T3 (da) 2011-06-06

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1120022T1 (el) Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
CY1117312T1 (el) Θεραπευτικη αγωγη συνουκλεϊνοπαθειων
MX391921B (es) Nepicastat para usarse en el tratamiento de dependencia
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
CY1114712T1 (el) Υδατικες φαρμακευτικες συνθεσεις περιεχουσες συμπλοκα βορικου-πολυολης
EA201001771A1 (ru) Лечение релаксином одышки, ассоциированной с острой сердечной недостаточностью
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
DK1809661T3 (da) Humant interferon-beta-mutein
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
EP2754447A3 (en) Treating acute renal failure with soluble thrombomodulin variants
UA88165C2 (xx) Застосування тризаміщених бензопіранонів$применение трехзамещенных бензопиранонов
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии
ATE503489T1 (de) Behandlung von akutem nierenversagen mit löslichem thrombomodulin
DK1880727T3 (da) Topisk vaginal farmaceutiske sammensætninger
DK1843771T3 (da) Anvendelse af pyrimidylaminobenzamider til behandling af sygdomme, der responderer på modulation af Tie-2-kinase-aktiviteten
TN2011000206A1 (en) Compositions and methods of use soluble thrombomodulin variants
TR201901012T4 (tr) Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı.
DE502006006241D1 (de) Verwendung von amino substituierten benzimidazolen
ATE465741T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
ATE454144T1 (de) Behandlung von malignen neoplasien
EA200801023A1 (ru) Применение фенофибрата или его производного для предотвращения диабетической ретинопатии